Raltitrexed — CAS 112887-68-0

Raltitrexed is a specific thymidylate synthase (TS) inhibitor used in the treatment of advanced colorectal cancer. It is a folate analogue that inhibits DNA synthesis. Mediocon Inc manufactures GMP-compliant Raltitrexed at its Aurangabad facility to international pharmacopoeial standards.

• Colorectal cancer treatment
• Thymidylate synthase inhibitor
• Antineoplastic / antifolate chemotherapy
• Palliative treatment of advanced colorectal carcinoma

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support